NCCN guidelines highlight ‘complicated’ treatment for pediatric lymphomasJanuary 14, 2020B Cell LymphomaAggressive LymphomasPediatricsDLBCL
Survival data reported from largest CAR T trial in B-cell lymphomaDecember 20, 2019B Cell LymphomaDLBCLIndolent Lymphoma
Care coordination, equity can eliminate disparities for nonwhite patients with DLBCLDecember 8, 2019DLBCLNon-Hodgkin Lymphoma
Adding polatuzumab extends survival in relapsed/refractory DLBCLNovember 16, 2019B Cell LymphomaDLBCL
Armored CAR T cells elicit responses in NHL patientsNovember 12, 2019B Cell LymphomaDLBCLCellular Therapy
CAR T-cell therapy found safe, effective for HIV-associated lymphomaSeptember 20, 2019B Cell LymphomaAggressive LymphomasDLBCLCellular Therapy
Chemo-free combo gets high response rate in relapsed or refractory DLBCLJuly 23, 2019B Cell LymphomaDLBCL
